-+ 0.00%
-+ 0.00%
-+ 0.00%

Oppenheimer Maintains Outperform on MediWound, Lowers Price Target to $32

Benzinga·05/28/2026 15:07:55
Listen to the news
Oppenheimer analyst Francois Brisebois maintains MediWound (NASDAQ:MDWD) with a Outperform and lowers the price target from $33 to $32.